CyberKnife® Always Precise
The CyberKnife® System treats lung lesions with sub-millimetre precision using Accuray’s Synchrony tracking algorithm to track tumours during breathing.
Lung cancer remains the 5th most commonly diagnosed cancer, yet remains the leading cause of cancer death in Australia each year (Cancer Australia). Treatment options depend largely on the type and stage of the disease at diagnosis; for example, early-stage lung cancers are generally treated with surgery, often in combination with chemotherapy.
Where surgery is not an option, radiation therapy can be given as a treatment in its own right or in combination with chemotherapy. In addition, radiation therapy can be used as an adjunct to surgery, generally in combination with chemotherapy (Nuyttens, J.J., et al., Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors. Radiother Oncol, 2012. 102(3): p. 383-7).
Primary and secondary malignant brain lesions.
Benign brain lesions such as AVM (Arteriovenous Malformation), acoustic neuroma, trigeminal neuralgia.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
The only treatment modality able to precisely target tumours as they move, the CyberKnife® System treats lung lesions with sub-millimetre precision using Accuray’s Synchrony tracking algorithm to track tumours during breathing. This allows for the delivery of biologically higher radiation doses whilst minimising impact on nearby healthy tissue and organs.
Our 5D Clinic specialists work closely with your existing medical team to determine whether CyberKnife® treatment is right for you.
Standard radiation delivery systems do not have this tracking ability and therefore irradiate larger areas of healthy lung tissue.
As a consequence, standard treatments are typically delivered in 30 or more low-dose treatment sessions over the course of 5 weeks, as opposed the CyberKnife® System’s ability to treat effectively and precisely in just 1 to 5 treatment sessions.
